These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 39112102)

  • 21. Comparative Efficacy of Sodium Zirconium Cyclosilicate and Sodium Polystyrene Sulfonate for Acute Hyperkalemia: A Retrospective Chart Review.
    Gonzalez J; Nayyar D
    Hosp Pharm; 2024 Apr; 59(2):159-164. PubMed ID: 38450357
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of the effect of sodium zirconium cyclosilicate on arrhythmia-related cardiovascular outcomes in patients receiving chronic haemodialysis with hyperkalaemia: protocol for the multicentre, randomised, controlled DIALIZE-Outcomes study.
    Fishbane S; Jadoul M; Dember L; Kovesdy CP; Al-Shurbaji A; Lisovskaja V; Sekar P; Katona B; Guzman N; Herzog C
    BMJ Open; 2023 May; 13(5):e071309. PubMed ID: 37230521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium zirconium cyclosilicate in hyperkalemia.
    Packham DK; Rasmussen HS; Lavin PT; El-Shahawy MA; Roger SD; Block G; Qunibi W; Pergola P; Singh B
    N Engl J Med; 2015 Jan; 372(3):222-31. PubMed ID: 25415807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population Pharmacodynamic Dose-Response Analysis of Serum Potassium Following Dosing with Sodium Zirconium Cyclosilicate.
    Penland RC; Åstrand M; Boulton DW; Någård M
    Clin Pharmacokinet; 2024 Apr; 63(4):551-560. PubMed ID: 38504082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia.
    Kashihara N; Yamasaki Y; Osonoi T; Harada H; Shibagaki Y; Zhao J; Kim H; Yajima T; Sarai N
    Clin Exp Nephrol; 2021 Feb; 25(2):140-149. PubMed ID: 33098526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia: REALIZE-K Design and Baseline Characteristics.
    Kosiborod MN; Cherney D; Connelly K; Desai AS; Guimarães PO; Kuthi L; Lala A; Madrini V; Merkely B; Villota JN; Squire I; Testani JM; Vaclavik J; Verma S; Wranicz J; Dahl M; Eudicone JM; Friberg L; Petrie MC
    JACC Heart Fail; 2024 May; ():. PubMed ID: 38878009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of sodium zirconium cyclosilicate on sodium and potassium excretion in healthy adults: a Phase 1 study.
    Någård M; Singh B; Boulton DW
    Clin Kidney J; 2021 Aug; 14(8):1924-1931. PubMed ID: 34345416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study.
    Roger SD; Lavin PT; Lerma EV; McCullough PA; Butler J; Spinowitz BS; von Haehling S; Kosiborod M; Zhao J; Fishbane S; Packham DK
    Nephrol Dial Transplant; 2021 Jan; 36(1):137-150. PubMed ID: 32030422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of effectiveness and safety of sodium polystyrene sulfonate and sodium zirconium cyclosilicate for treatment of hyperkalemia in hospitalized patients.
    Sullivan E; Ruegger M; Dunne I; Sutaria N; Towers WF
    Am J Health Syst Pharm; 2023 Sep; 80(18):1238-1246. PubMed ID: 37335862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of hyperkalemia in chronic heart failure using sodium zirconium cyclosilicate.
    Oshima A; Imamura T; Narang N; Kinugawa K
    Clin Cardiol; 2021 Sep; 44(9):1272-1275. PubMed ID: 34263946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of different potassium-lowering regimens on acute hyperkalemia in hemodialysis patients: a real-world, retrospective study.
    Yao L; Xing X; Li Y; Zhang F; Li P; Liang X; Wang P
    J Transl Med; 2022 Jul; 20(1):333. PubMed ID: 35879718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of sodium zirconium cyclosilicate for the management of acute and chronic hyperkalemia in children with chronic kidney disease 4-5 and on dialysis.
    Khandelwal P; Shah S; McAlister L; Cleghorn S; King L; Shroff R
    Pediatr Nephrol; 2024 Apr; 39(4):1213-1219. PubMed ID: 37857905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of Patiromer Versus Sodium Zirconium Cyclosilicate for the Management of Acute Hyperkalemia.
    Rydell A; Thackrey C; Molki M; Mullins BP
    Ann Pharmacother; 2024 Aug; 58(8):790-795. PubMed ID: 37953506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial.
    Anker SD; Kosiborod M; Zannad F; Piña IL; McCullough PA; Filippatos G; van der Meer P; Ponikowski P; Rasmussen HS; Lavin PT; Singh B; Yang A; Deedwania P
    Eur J Heart Fail; 2015 Oct; 17(10):1050-6. PubMed ID: 26011677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potassium-lowering effects of sodium zirconium cyclosilicate in the early post-transplant period.
    Shockey W; Wiegel JJ; Parajuli S; Garg N; Swanson KJ; Mandelbrot DA
    Clin Transplant; 2024 Jan; 38(1):e15156. PubMed ID: 37812572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical Costs in Patients with Hyperkalemia on Long-Term Sodium Zirconium Cyclosilicate Therapy: The RECOGNIZE II Study.
    Agiro A; Dwyer JP; Oluwatosin Y; Desai P
    Clinicoecon Outcomes Res; 2023; 15():691-702. PubMed ID: 37753303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patiromer and Sodium Zirconium Cyclosilicate in Treatment of Hyperkalemia: A Systematic Review and Meta-Analysis.
    Shrestha DB; Budhathoki P; Sedhai YR; Baniya R; Cable CA; Kashiouris MG; Dixon DL; Kidd JM; Adhikari Y; Marasini A; Bhandari S
    Curr Ther Res Clin Exp; 2021; 95():100635. PubMed ID: 34367383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Course of Hyperkalemia in Patients on Hemodialysis.
    Spinowitz B; Fishbane S; Fukagawa M; Ford M; Guzman N; Rastogi A
    Int J Nephrol; 2022; 2022():6304571. PubMed ID: 35531468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of sodium zirconium cyclosilicate as a treatment option for hyperkalemia.
    Takkar C; Nassar T; Qunibi W
    Expert Opin Pharmacother; 2021 Jan; 22(1):19-28. PubMed ID: 32892634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constipation as a Drug-Related Adverse Effect in Patients with Hyperkalemia: Sodium Zirconium Cyclosilicate versus Conventional Potassium Binders.
    Hida Y; Imamura T; Kinugawa K
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.